Patent · US Active

Vector production

US10912824B2 · kind B2 · utility

2Cited by
1References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 13, 2015
Grant dateFeb 9, 2021
Priority date
Expiry dateJul 13, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An enveloped viral particle producer or packaging cell, wherein the cell is genetically engineered to decrease expression of MHC-I on the surface of the cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.